Archive: 06/09/2017
Nivolumab in head and neck squamous cell carcinoma: Added benefit for specific patients
Nivolumab (trade name: Opdivo) has been approved since June 2017 for adults with squamous cell carcinoma of the head and neck. The drug is an option if platinum-based chemotherapy is not sufficiently effective against this ...
Sep 6, 2017
Late bedtime and lack of sleep lead to overweight children in China
Researchers at the University of Birmingham have found that Chinese children who go to bed later and sleep less are more likely to be more overweight.
Sep 6, 2017